These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 12021173)

  • 1. Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure.
    Kooptiwut S; Zraika S; Thorburn AW; Dunlop ME; Darwiche R; Kay TW; Proietto J; Andrikopoulos S
    Endocrinology; 2002 Jun; 143(6):2085-92. PubMed ID: 12021173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.
    Kooptiwut S; Kebede M; Zraika S; Visinoni S; Aston-Mourney K; Favaloro J; Tikellis C; Thomas MC; Forbes JM; Cooper ME; Dunlop M; Proietto J; Andrikopoulos S
    J Mol Endocrinol; 2005 Aug; 35(1):39-48. PubMed ID: 16087720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucokinase, hexokinase, glucose transporter 2, and glucose metabolism in islets during pregnancy and prolactin-treated islets in vitro: mechanisms for long term up-regulation of islets.
    Weinhaus AJ; Stout LE; Sorenson RL
    Endocrinology; 1996 May; 137(5):1640-9. PubMed ID: 8612496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of pancreatic beta-cell glucokinase by antisense RNA expression in transgenic mice: mouse strain-dependent alteration of glucose tolerance.
    Ishihara H; Tashiro F; Ikuta K; Asano T; Katagiri H; Inukai K; Kikuchi M; Yazaki Y; Oka Y; Miyazaki J
    FEBS Lett; 1995 Sep; 371(3):329-32. PubMed ID: 7556622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of streptozotocin, tumor necrosis factor-alpha, and interleukin-1beta on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase.
    Park C; Kim JR; Shim JK; Kang BS; Park YG; Nam KS; Lee YC; Kim CH
    Arch Biochem Biophys; 1999 Feb; 362(2):217-24. PubMed ID: 9989930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
    Jetton TL; Liang Y; Cincotta AH
    Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose uptake, utilization, and signaling in GLUT2-null islets.
    Guillam MT; Dupraz P; Thorens B
    Diabetes; 2000 Sep; 49(9):1485-91. PubMed ID: 10969832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets.
    Zraika S; Aston-Mourney K; Laybutt DR; Kebede M; Dunlop ME; Proietto J; Andrikopoulos S
    Diabetologia; 2006 Jun; 49(6):1254-63. PubMed ID: 16570159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes.
    Cockburn BN; Ostrega DM; Sturis J; Kubstrup C; Polonsky KS; Bell GI
    Diabetes; 1997 Sep; 46(9):1434-9. PubMed ID: 9287043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice.
    Reimer MK; Ahrén B
    Diabetes; 2002 Feb; 51 Suppl 1():S138-43. PubMed ID: 11815473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet.
    Andrikopoulos S; Massa CM; Aston-Mourney K; Funkat A; Fam BC; Hull RL; Kahn SE; Proietto J
    J Endocrinol; 2005 Oct; 187(1):45-53. PubMed ID: 16214940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation by glucose of insulin secretion and glucose phosphorylating activity in cultured pancreatic islets from obese (fa/fa) Zucker rats.
    Chan CB; Lowe JM; Debertin WJ
    Int J Obes Relat Metab Disord; 1996 Feb; 20(2):175-84. PubMed ID: 8646255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Km of GLUT-2 glucose transporter does not explain its role in insulin secretion.
    Lachaal M; Spangler RA; Jung CY
    Am J Physiol; 1993 Dec; 265(6 Pt 1):E914-9. PubMed ID: 8279547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice.
    Toye AA; Lippiat JD; Proks P; Shimomura K; Bentley L; Hugill A; Mijat V; Goldsworthy M; Moir L; Haynes A; Quarterman J; Freeman HC; Ashcroft FM; Cox RD
    Diabetologia; 2005 Apr; 48(4):675-86. PubMed ID: 15729571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic reexpression of GLUT1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion.
    Thorens B; Guillam MT; Beermann F; Burcelin R; Jaquet M
    J Biol Chem; 2000 Aug; 275(31):23751-8. PubMed ID: 10823833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2.
    Guillam MT; Hümmler E; Schaerer E; Yeh JI; Birnbaum MJ; Beermann F; Schmidt A; Dériaz N; Thorens B
    Nat Genet; 1997 Nov; 17(3):327-30. PubMed ID: 9354799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of starvation on insulin secretion and glucose metabolism in mouse pancreatic islets.
    Hedeskov CJ; Capito K
    Biochem J; 1974 Jun; 140(3):423-33. PubMed ID: 4155624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes induced by sucrose administration on glucose metabolism in pancreatic islets in normal hamsters.
    Massa ML; Borelli MI; Del Zotto H; Gagliardino JJ
    J Endocrinol; 2001 Dec; 171(3):551-6. PubMed ID: 11739021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
    Liang Y; Lubkin M; Sheng H; Scislowski PW; Cincotta AH
    Biochim Biophys Acta; 1998 Oct; 1405(1-3):1-13. PubMed ID: 9784590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.